AI assistant
Sending…
Brainsway Ltd. — M&A Activity 2025
Aug 20, 2025
6701_rns_2025-08-20_b18b986c-6f2d-46bb-bc04-ebb744d5a984.htm
M&A Activity
Open in viewerOpens in your device viewer
BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health false
| בריינסוויי בע"מ | 2 380 |
| BRAINSWAY LTD | |
| Corporation no: 513890764 | 10767 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 19/08/2025 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2025-02-061595 | Time of broadcast: 10:28 10:28 |
The corporation scheduled the publication of the report to 20/08/2025 14:30Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onBrainsWay Acquires Minority-Stake in Axis Integrated Mental Health
6K_BrainsWay_Investment_in_Axis_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: BWAY | Date of revision of form structure: 06/08/2024 |
| Address: הרטום 19 , ירושלים 91451 , Tel: 02-5813140 , Fax: 02-5812517 | |
| E-mail address: [email protected] Company site: www.Brainsway.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: Levy Hadar Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company: | |
| Address: Hartum Street, Bynet Building 19 , Jerusalem 9777518 Telephone: 97225824030 Facsimile: 97225812517 E-mail: [email protected] 1 | |
More from Brainsway Ltd.
Director's Dealing
2026
May 21
Director's Dealing
2026
May 21
Regulatory Filings
2026
May 18
Report Publication Announcement
2026
May 18
Report Publication Announcement
2026
May 13
Investor Presentation
2026
May 13
Interim / Quarterly Report
2026
May 13
Report Publication Announcement
2026
May 13
Report Publication Announcement
2026
Apr 20
Regulatory Filings
2026
Apr 20